New drug shows promise in keeping HBV-Linked lymphoma at bay
Disease control
Completed
This study tested the drug chidamide as a maintenance therapy for 30 people with hepatitis B virus (HBV)-positive diffuse large B-cell lymphoma who had already achieved complete remission after chemotherapy. The goal was to see if chidamide could help keep the cancer from returni…
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 04, 2026 16:19 UTC